Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Reply to S. Kusumoto et al.

Huang YH, Lin HC, Lee SD.

J Clin Oncol. 2013 Dec 10;31(35):4481. doi: 10.1200/JCO.2013.53.4255. Epub 2013 Nov 12. No abstract available.

PMID:
24220562
[PubMed - indexed for MEDLINE]
2.

Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B.

Huang YH, Hsiao LT, Hong YC, Chiou TJ, Yu YB, Gau JP, Liu CY, Yang MH, Tzeng CH, Lee PC, Lin HC, Lee SD.

J Clin Oncol. 2013 Aug 1;31(22):2765-72. doi: 10.1200/JCO.2012.48.5938. Epub 2013 Jun 17.

PMID:
23775967
[PubMed - indexed for MEDLINE]
3.

Is antiviral prophylaxis necessary to prevent hepatitis B virus (HBV) reactivation in patients with HBV-resolved infection receiving rituximab-containing chemotherapy?

Kusumoto S, Tanaka Y, Mizokami M, Ueda R.

J Clin Oncol. 2013 Dec 10;31(35):4480. doi: 10.1200/JCO.2013.52.1278. Epub 2013 Nov 12. No abstract available.

PMID:
24220561
[PubMed - indexed for MEDLINE]
4.

Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma.

Cho CH, Hwang WL, Cheng SB, Lee TY, Teng CL.

Ann Hematol. 2011 Jan;90(1):111-2. doi: 10.1007/s00277-010-0962-9. Epub 2010 Apr 21. No abstract available.

PMID:
20407894
[PubMed - indexed for MEDLINE]
5.

Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma.

Uchiyama M, Tamai Y, Ikeda T.

Int J Infect Dis. 2010 Mar;14(3):e265-6. doi: 10.1016/j.ijid.2009.04.014. Epub 2009 Aug 7. No abstract available.

PMID:
19665406
[PubMed - indexed for MEDLINE]
Free Article
6.

Reactivation of resolved hepatitis B during rituximab therapy for rheumatoid arthritis.

Ghrénassia E, Mékinian A, Rouaghe S, Ganne N, Fain O.

Joint Bone Spine. 2012 Jan;79(1):100-1. doi: 10.1016/j.jbspin.2011.07.003. Epub 2011 Sep 23. No abstract available.

PMID:
21944979
[PubMed - indexed for MEDLINE]
7.

Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.

Kim SJ, Hsu C, Song YQ, Tay K, Hong XN, Cao J, Kim JS, Eom HS, Lee JH, Zhu J, Chang KM, Reksodiputro AH, Tan D, Goh YT, Lee J, Intragumtornchai T, Chng WJ, Cheng AL, Lim ST, Suh C, Kwong YL, Kim WS.

Eur J Cancer. 2013 Nov;49(16):3486-96. doi: 10.1016/j.ejca.2013.07.006. Epub 2013 Aug 1.

PMID:
23910494
[PubMed - indexed for MEDLINE]
8.

Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy.

Cheung WI, Lin SY, Leung VK, Fung KS, Lam YK, Lo FH, Chau TN.

Hong Kong Med J. 2011 Oct;17(5):376-80.

PMID:
21979474
[PubMed - indexed for MEDLINE]
Free Article
9.

Hepatitis B surface antigen seroreversion in a T-cell lymphoma patient.

Chen HW, Lin SA, Lin HC, Kao WY.

J BUON. 2011 Apr-Jun;16(2):374-6. No abstract available.

PMID:
21766517
[PubMed - indexed for MEDLINE]
10.

Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient.

Feeney SA, McCaughey C, Watt AP, Agnaf MR, McDougall N, Wend UC, Gerlich WH, Coyle PV.

J Med Virol. 2013 Apr;85(4):597-601. doi: 10.1002/jmv.23513. Epub 2013 Jan 28.

PMID:
23359331
[PubMed - indexed for MEDLINE]
11.

The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy.

Chen XQ, Peng JW, Lin GN, Li M, Xia ZJ.

Med Oncol. 2012 Jun;29(2):1237-41. doi: 10.1007/s12032-011-9974-0. Epub 2011 May 10.

PMID:
21556931
[PubMed - indexed for MEDLINE]
12.

Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.

Coiffier B.

Cancer Invest. 2006 Aug-Sep;24(5):548-52. Review.

PMID:
16939967
[PubMed - indexed for MEDLINE]
13.

Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy.

Niscola P, Del Principe MI, Maurillo L, Venditti A, Buccisano F, Piccioni D, Amadori S, Del Poeta G.

Leukemia. 2005 Oct;19(10):1840-1. No abstract available.

PMID:
16094417
[PubMed - indexed for MEDLINE]
14.

A study of hepatitis B virus reactivation associated with rituximab therapy in real-world clinical practice: a single-center experience.

Oh MJ, Lee HJ.

Clin Mol Hepatol. 2013 Mar;19(1):51-9. doi: 10.3350/cmh.2013.19.1.51. Epub 2013 Mar 25.

PMID:
23593610
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: a case report and literature review.

Ferreira R, Carvalheiro J, Torres J, Fernandes A, Giestas S, Mendes S, Agostinho C, Campos MJ.

Saudi J Gastroenterol. 2012 Jul-Aug;18(4):277-81. doi: 10.4103/1319-3767.98436. Review.

PMID:
22824772
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation.

Liu CY, Chandrasekar PH, Masood A, Schiffer CA.

J Oncol Pharm Pract. 2013 Mar;19(1):18-23. doi: 10.1177/1078155212447975. Epub 2012 May 25.

PMID:
22635416
[PubMed - indexed for MEDLINE]
17.

Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.

Tseng TC, Liu CJ, Hsieh SC, Chen PJ, Lai MY, Chen DS, Kao JH.

Dig Liver Dis. 2009 Apr;41(4):322-3. doi: 10.1016/j.dld.2008.08.007. Epub 2008 Oct 10. No abstract available.

PMID:
18848814
[PubMed - indexed for MEDLINE]
18.

Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.

Wu JM, Huang YH, Lee PC, Lin HC, Lee SD.

J Clin Gastroenterol. 2009 May-Jun;43(5):496-8. doi: 10.1097/MCG.0b013e3181945942.

PMID:
19247200
[PubMed - indexed for MEDLINE]
19.

Reactivation of hepatitis B virus in rheumatologic patients receiving immunosuppressive agents.

Tsai FC, Hsieh SC, Chen DS, Sheu JC, Chen CH.

Dig Dis Sci. 2006 Sep;51(9):1627-32. Epub 2006 Aug 22. No abstract available. Erratum in: Dig Dis Sci. 2007 Dec;52(12):3533. Chen, Ding-Shinn [removed]; Chen, Chien-Hung [added].

PMID:
16927141
[PubMed - indexed for MEDLINE]
20.

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.

Koo YX, Tay M, Teh YE, Teng D, Tan DS, Tan IB, Tai DW, Quek R, Tao M, Lim ST.

Ann Hematol. 2011 Oct;90(10):1219-23. doi: 10.1007/s00277-011-1241-0. Epub 2011 Apr 26.

PMID:
21520001
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk